Preserved in vitro immunoreactivity in children receiving long-term immunosuppressive therapy due to inflammatory bowel disease or autoimmune hepatitis.

Schleker, Teresa; Jacobsen, Eva-Maria; Mayer, Benjamin; Strauss, Gudrun; Debatin, Klaus-Michael; Posovszky, Carsten

Schleker, Teresa; Jacobsen, Eva-Maria; Mayer, Benjamin; Strauss, Gudrun; Debatin, Klaus-Michael; Posovszky, Carsten.

Afiliação

Schleker T; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
Jacobsen EM; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
Mayer B; Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.
Strauss G; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
Debatin KM; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
Posovszky C; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany. carsten.posovszky@uniklinik-ulm.de.

Mol Cell Pediatr ; 5(1): 1, 2018 Jan 19.

Article em En | MEDLINE | ID: mdl-29352427